Precision treatment patterns and prognostic analysis: A retrospective study of small-cell lung cancer

View Full Paper

Ask AI

Bookmark

Patients with limited-stage SCLC had a median overall survival of 33.4 months, indicating promising treatment outcomes.
First-line thoracic consolidative radiotherapy significantly prolonged progression-free survival in extensive-stage patients, with P=0.023.
Starting TRT early, during or before the second cycle of chemotherapy, significantly improved survival outcomes in limited-stage patients.
Patients with more lymph node metastasis showed poorer prognosis, emphasizing the need for tailored treatment strategies.

Discussion

No takes yet. Share an insight, caveat, or question.

Retrospective study evaluates treatment patterns and survival outcomes in small-cell lung cancer patients, indicating efficacy of therapies.

Wang et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Retrospective study evaluates treatment patterns and survival outcomes in small-cell lung cancer patients, indicating efficacy of therapies.